The BANDIT trial is a clinical study designed to evaluate whether the drug baricitinib can slow the progressive loss of insulin-producing beta cells in individuals recently diagnosed with type 1 diabe
aAll summary ORs/RRs (95% CIs) were calculated by the random-effect model.bWe excluded three studies using the risk estimates with SIRs ([14] and [32]) and the different definition of diabetes ([33]wa
Data are presented as n, mean (SD) or %. *on average 50–60% reduction in n.†Significant difference between groups, except between NewT2D and DiagnosedT2D,‡% only mandatory education.§Glomerular filtra
